Discovery of KDM5D as a novel biomarker for traumatic brain injury identified through bioinformatics analysis
Based on the results of bioinformatics analysis and animal experiments, KDM5D serves as a potential biomarker for the diagnosis and prognosis of TBI. Additionally, research on KDM5D may develop into new serum markers, providing new indicators for further clinical liquid biopsy and aiding in the prevention of both TBI and tumors to a certain extent.
Authors
- Dengfeng Ding (ORCID: https://orcid.org/0000-0002-7360-2200)
- Ming Zhao (ORCID: https://orcid.org/0000-0002-8134-5769)
- Xinou Zheng
- Mengzhe Yang (ORCID: https://orcid.org/0009-0005-1905-6420)
Institutions
- Capital Medical University (CN)
- Chinese PLA General Hospital (CN)
- Beijing Anzhen Hospital (CN)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2025-03-24
- DOI
- https://doi.org/10.3389/fimmu.2025.1538561
- Citations
- 2
- Primary Topic
- S100 Proteins and Annexins
- Type
- article
- Field-Weighted Citation Impact
- 1.61
Funders
- National Natural Science Foundation of China